Improved two-stage estimation to adjust for treatment switching in randomised trials: g-estimation to address time-dependent confounding
{{output}}
In oncology trials, control group patients often switch onto the experimental treatment during follow-up, usually after disease progression. In this case, an intention-to-treat analysis will not address the policy question of interest - that of whether the new... ...
